KI67 AS A SURROGATE MARKER FOR MITOTIC KARYORRHECTIC INDEX IN NEUROBLASTOMA
Objective: To evaluate the use of Ki67 as a surrogate marker for Mitotic Karyorrhectic Index (MKI) in Neuroblastoma. Study Design: Cross-sectional study. Place and Duration of Study: This was a retrospective study conducted at Department of Histopathology, Shaukat Khanum Memorial Cancer Hospit...
Main Authors: | Rabia Javed, Sajid Mushtaq, Noreen Akhtar, Usman Hassan, Asif Loya |
---|---|
Format: | Article |
Language: | English |
Published: |
Army Medical College Rawalpindi
2020-04-01
|
Series: | Pakistan Armed Forces Medical Journal |
Subjects: | |
Online Access: | https://www.pafmj.org/index.php/PAFMJ/article/view/4240/2654 |
Similar Items
-
Using Ki-67 Mitotic Activity Markers as a Predictor of the Progression of Adhesions in the Abdominal Cavity
by: Irina A. Shurygina, et al.
Published: (2020-12-01) -
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
by: Karin Beelen, et al.
Published: (2018-07-01) -
Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
by: Nasrin Shayanfar, et al.
Published: (2010-06-01) -
The intrinsically disorderly story of Ki-67
by: Lucy Remnant, et al.
Published: (2021-08-01) -
EVALUATION OF P53 AND KI67 PROLIFERATIVE INDEX IN TRIPLE NEGATIVE BREAST CARCINOMA
by: Farhan AKhtar, et al.
Published: (2020-02-01)